263 related articles for article (PubMed ID: 27496232)
1. Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.
Tuñón J; González-Hernández I; Llanos-Jiménez L; Alonso-Martín J; Escudier-Villa JM; Tarín N; Cristóbal C; Sanz P; Pello AM; Aceña Á; Carda R; Orejas M; Tomás M; Beltrán P; Calero Rueda M; Marcos E; Serrano-Antolín JM; Gutiérrez-Landaluce C; Jiménez R; Cabezudo J; Curcio A; Peces-Barba G; González-Parra E; Muñoz-Siscart R; González-Casaus ML; Lorenzo A; Huelmos A; Goicolea J; Ibáñez B; Hernández G; Alonso-Pulpón LM; Farré J; Lorenzo Ó; Mahíllo-Fernández I; Egido J
BMJ Open; 2016 Aug; 6(8):e011287. PubMed ID: 27496232
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study.
Pezel T; Besseyre des Horts T; Schaaf M; Croisille P; Bière L; Garcia-Dorado D; Jossan C; Roubille F; Cung TT; Prunier F; Meyer E; Amaz C; Derumeaux G; de Poli F; Hovasse T; Gilard M; Bergerot C; Thibault H; Ovize M; Mewton N
Arch Cardiovasc Dis; 2020 Nov; 113(11):710-720. PubMed ID: 33160891
[TBL] [Abstract][Full Text] [Related]
3. Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial.
Boyle AJ; Schultz C; Selvanayagam JB; Moir S; Kovacs R; Dib N; Zlotnick D; Al-Omary M; Sugito S; Selvarajah A; Collins N; McLachlan G
JAMA Cardiol; 2021 Jul; 6(7):762-768. PubMed ID: 33851966
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.
Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G;
Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial.
Hubers SA; Schirger JA; Sangaralingham SJ; Chen Y; Burnett JC; Hodge D; Chen HH
Heart; 2021 Mar; 107(5):396-402. PubMed ID: 32747497
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Mueller L; Koch C; Mayr A; Theurl M; Kirchmair R; Klug G; Metzler B
Heart; 2017 Jun; 103(11):856-862. PubMed ID: 27979879
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Türkoğlu C; Gür M; Şeker T; Selek Ş; Koçyiğit A
Coron Artery Dis; 2016 Dec; 27(8):690-695. PubMed ID: 27479531
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
[TBL] [Abstract][Full Text] [Related]
9. Predictors of left ventricular remodeling after ST-elevation myocardial infarction.
Hendriks T; Hartman MHT; Vlaar PJJ; Prakken NHJ; van der Ende YMY; Lexis CPH; van Veldhuisen DJ; van der Horst ICC; Lipsic E; Nijveldt R; van der Harst P
Int J Cardiovasc Imaging; 2017 Sep; 33(9):1415-1423. PubMed ID: 28389968
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
Caplice NM; DeVoe MC; Choi J; Dahly D; Murphy T; Spitzer E; Van Geuns R; Maher MM; Tuite D; Kerins DM; Ali MT; Kalyar I; Fahy EF; Khider W; Kelly P; Kearney PP; Curtin RJ; O'Shea C; Vaughan CJ; Eustace JA; McFadden EP
Am Heart J; 2018 Jun; 200():110-117. PubMed ID: 29898838
[TBL] [Abstract][Full Text] [Related]
11. Effects of spironolactone on cardiac sympathetic nerve activity and left ventricular remodelling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction.
Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
Heart; 2011 May; 97(10):817-22. PubMed ID: 21378011
[TBL] [Abstract][Full Text] [Related]
12. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Traverse JH; Henry TD; Pepine CJ; Willerson JT; Chugh A; Yang PC; Zhao DXM; Ellis SG; Forder JR; Perin EC; Penn MS; Hatzopoulos AK; Chambers JC; Baran KW; Raveendran G; Gee AP; Taylor DA; Moyé L; Ebert RF; Simari RD
Circ Res; 2018 Feb; 122(3):479-488. PubMed ID: 29208679
[TBL] [Abstract][Full Text] [Related]
13. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Janssens S; Dubois C; Bogaert J; Theunissen K; Deroose C; Desmet W; Kalantzi M; Herbots L; Sinnaeve P; Dens J; Maertens J; Rademakers F; Dymarkowski S; Gheysens O; Van Cleemput J; Bormans G; Nuyts J; Belmans A; Mortelmans L; Boogaerts M; Van de Werf F
Lancet; 2006 Jan; 367(9505):113-21. PubMed ID: 16413875
[TBL] [Abstract][Full Text] [Related]
15. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM
Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial.
Gastelurrutia P; Gálvez-Montón C; Cámara ML; Bustamante-Munguira J; García-Pavia P; Avanzas P; Alberto San Román J; Pascual-Figal D; Teresa E; Crespo-Leiro MG; Manito N; Núñez J; Fernández-Avilés F; Caballero Á; Teis A; Lupón J; Brugada R; Martín C; Silva J; Revilla-Orodea A; Cánovas SJ; Melero JM; Cuenca-Castillo JJ; Gonzalez-Pinto A; Bayes-Genis A
BMJ Open; 2017 Aug; 7(8):e017187. PubMed ID: 28780562
[TBL] [Abstract][Full Text] [Related]
18. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P
Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
Janssens SP; Bogaert J; Zalewski J; Toth A; Adriaenssens T; Belmans A; Bennett J; Claus P; Desmet W; Dubois C; Goetschalckx K; Sinnaeve P; Vandenberghe K; Vermeersch P; Lux A; Szelid Z; Durak M; Lech P; Zmudka K; Pokreisz P; Vranckx P; Merkely B; Bloch KD; Van de Werf F;
Eur Heart J; 2018 Aug; 39(29):2717-2725. PubMed ID: 29800130
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
